From HKIDEAS to VIDEC 2026: Junxiu（Rosemond）’s Dental Exhibition Visits
Two exhibitions. Two cities. One global journey. From HKIDEAS in Hong Kong to VIDEC 2026 in Vietnam,…
Junxiu（Rosemond） at the 40th IADR-SEA Annual Scientific Meeting
Junxiu（Rosemond） participated in the 40th IADR-SEA Annual Scientific Meeting in Phnom Penh, Cambodia, showcasing our dental biomaterials…
Strengthening Dialogue, Advancing Regeneration: Junxiu Biotech Chairperson Visits Geistlich Pharma’s Swiss Headquarters
Gao Xiuyan, Chairperson of Junxiu Biotech, recently visited Geistlich Pharma’s headquarters in Switzerland for in-depth discussions with…
Junxiu Biotech’s Absorbable Dural Sealant Enters China’s Special Review Procedure for Innovative Medical Devices
Shandong Junxiu Biotechnology Co., Ltd. (“Junxiu Biotech”) has reached an important regulatory milestone with its independently developed…
JUNXIU Biotech has long focused on biomedical materials and high-end implantable medical devices, with a commitment to advancing tissue repair and regenerative medicine through innovative material technologies
JUNXIU Biotech has long focused on biomedical materials and high-end implantable medical devices, with a commitment to…
Geistlich Pharma Management Team Visits Junxiu Biotech
On July 7, 2026, Mr. Diego Gabathuler, Chief Executive Officer of Geistlich Pharma AG, led a seven-member…
Junxiu Biotech Strengthens Global Footprint and Accelerates Overseas Expansion
On June 5th, important partners from the Eurasian region visited Shandong Junxiu Biotechnology Co., Ltd. The two…
Junxiu Biological has passed DNV international certification, stepping up the pace of its global strategic layout.
Recently, Shandong Junxiu Biotechnology Co., Ltd. has officially been granted the ISO 13485 Medical Device Quality Management…